Cargando…
Blood clots and TAM receptor signalling in COVID-19 pathogenesis
We suggest that the exuberant blood clotting and immune hyper-reaction seen in patients with COVID-19 may be exacerbated by depletion of the same regulator. This agent is protein S, which is both an anticoagulant in the blood coagulation cascade and an activating ligand for the immunosuppressive TAM...
Autores principales: | Lemke, Greg, Silverman, Gregg J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264968/ https://www.ncbi.nlm.nih.gov/pubmed/32488201 http://dx.doi.org/10.1038/s41577-020-0354-x |
Ejemplares similares
-
Diversification of TAM receptor function
por: Zagórska, Anna, et al.
Publicado: (2014) -
TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019) -
Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014) -
Early death in a mouse model of Alzheimer’s disease exacerbated by microglial loss of TAM receptor signaling
por: Huang, Youtong, et al.
Publicado: (2022) -
Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer
por: Happonen, Kaisa E., et al.
Publicado: (2023)